Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
HIV-1-infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aarhus University Hospital, Aarhus, Denmark
Contact: Study coordinator (Jesper D Gunst, MD)
Study leads
Thomas A Rasmussen
Principal Investigator
Department of Infectious Diseases, Aarhus University Hospital
Sharon R Lewin
Principal Investigator
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), University of Melbourne